Compositions comprising an HIV protease inhibitor such as Vx 478 and a water soluble vitamin E compound such as vitamin E-TPGS.

摘要

Pharmaceutical formulations containing hiv protease inhibitors, specifically including 3s-[3r*(1r*,2s*)]-[3-[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-phenylmethyl)propryl]carbamic acid, tetrahydro-3-furanyl ester (alternatively known